Eli Lilly and Nvidia are experiencing positive momentum, with Lilly's stock rising after an analyst upgrade and Nvidia showcasing impressive Q4 earnings. Both companies are key players in shaping the future of healthcare and technology. Read more...

Several institutional investors, including Oppenheimer, Principal, and Rhumbline, adjusted their holdings in various companies during the fourth quarter, according to recent reports. Read more...

Several investment firms made notable moves in the fourth quarter, adjusting their positions in companies like Apple, Amazon, and Johnson & Johnson. Here's a look at the key trades. Read more...